VAS
TXG icon

Vestmark Advisory Solutions’s 10x Genomics TXG Stock Holding History

Vestmark Advisory Solutions’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.16M Sell
212,877
-38,153
-15% -$1,000K 0.08% 276
2026
Q1 		$5.33M Sell
251,030
-19,638
-7% -$393K 0.06% 331
2025
Q4 		$4.41M Sell
270,668
-3,772
-1% -$57K 0.06% 327
2025
Q3 		$3.21M Sell
274,440
-340,854
-55% -$4.44M 0.06% 324
2025
Q2 		$7.13M Buy
615,294
+321,894
+110% +$2.93M 0.1% 150
2025
Q1 		$2.56M Sell
293,400
-2,139
-0.7% -$27K 0.07% 296
2024
Q4 		$5.02M Buy
295,539
+47,357
+19% +$747K 0.17% 121
2024
Q3 		$5.6M Buy
248,182
+59,855
+32% +$1.24M 0.21% 99
2024
Q2 		$3.66M Buy
188,327
+32,284
+21% +$845K 0.15% 147
2024
Q1 		$5.86M Buy
156,043
+78,634
+102% +$3.45M 0.25% 89
2023
Q4 		$4.33M Buy
+77,409
New +$3.37M 0.22% 114
2022
Q3 		– Sell
-9,913
Closed -$448K – 878
2022
Q2 		$448K Sell
9,913
-753
-7% -$39.1K 0.03% 567
2022
Q1 		$811K Buy
10,666
+5,070
+91% +$444K 0.05% 414
2021
Q4 		$833K Buy
+5,596
New +$857K 0.05% 402

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vestmark Advisory Solutions's TXG Position: Q2 2026 in Review

Vestmark Advisory Solutions reduced its 10x Genomics (TXG) stake by 15% in Q2 2026, selling an estimated $1,000K and leaving 212,877 shares worth $8.16M. The position accounts for 0.08% of the portfolio, ranked #276.

Vestmark Advisory Solutions first reported a position in TXG in Q4 2021 and has held it in 14 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Vestmark Advisory Solutions held 212,877 shares of 10x Genomics worth $8.16M as of Q2 2026.
  • Vestmark Advisory Solutions sold 38,153 10x Genomics shares in Q2 2026, an estimated $1,000K.
  • 10x Genomics made up 0.08% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #276 holding.
  • Vestmark Advisory Solutions first reported a position in 10x Genomics in Q4 2021 and has held it in 14 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.